UCL and Limeway Pharma Design
Adrian Davis, a physical pharmaceutical chemist, joined Beecham Group in 1971 until 2004 when he retired as Director of Dermatological New Product Research in, the then, GlaxoSmithKline company. He is the author of over 30 patents, the majority of which are in the area of dermatological drug delivery, his specialist area for the last thirty plus years. He has published both original research and review chapters in the area of dermatological drug delivery and is a reviewer for several international journals. His particular interest is in rational drug dosage and drug delivery to optimize therapeutic potential. He uses, promotes and teaches the concept of Pharmaceutical Design whereby drug design, formulation design and product design, and thus for the latter, consumer needs and competitive positioning, are integrated into an initial design plan.